Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 1;21(8):64.
doi: 10.1007/s11920-019-1051-y.

Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature

Affiliations
Review

Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature

Chloé Tezenas du Montcel et al. Curr Psychiatry Rep. .

Abstract

Purpose of review: This review will aim to summarize the current body of epidemiological, clinical and therapeutic knowledge concerning specific co-occurrence of obsessive-compulsive symptoms (OCSs) and schizophrenia spectrum disorder.

Recent findings: Almost 30% of the patients with schizophrenia display OCS, and three main contexts of emergence are identified: prodromal symptoms of schizophrenia, co-occurrence of OCS and schizophrenia and antipsychotics-induced OCS. Recent clinical studies show that patients with SZ and OCS have more severe psychotic and depressive symptoms, higher suicidality and lower social functioning. A recent cognitive investigation found that OCS and delusions share specific metacognitive profiles, particularly through a heightened need to control thoughts. Finally, a recent cross-sectional study of clozapine-induced OCS found a dose-response relationship between clozapine and OCS. OCS appeared reliably as linked to poorer outcomes among patients with schizophrenia. However, the specific clinical value of OCS among other prodromal symptoms of schizophrenia remains unknown.

Keywords: Antipsychotics; Obsessive-compulsive disorder; Obsessive-compulsive symptoms; Schizo-obsessive disorder; Schizophrenia; Ultra-high risk (UHR) of psychosis.

PubMed Disclaimer

References

    1. J Clin Psychiatry. 1999 Jun;60(6):364-5 - PubMed
    1. Pharmacopsychiatry. 2000 Nov;33(6):236-8 - PubMed
    1. Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):283-6 - PubMed
    1. J Clin Psychiatry. 1992 Dec;53(12):439-42 - PubMed
    1. Int J Neuropsychopharmacol. 2005 Mar;8(1):107-29 - PubMed

MeSH terms

LinkOut - more resources